SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015Approved Regimens for Cirrhotic Patients - Marina BerenguerView Slideset
SlidesetWorkshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015Approved Regimens for Non ‐Cirrhotic Patients - Graham Foster, FRCP, PhDView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Real-time and non-invasive, multi-compartment pharmacokinetics of 11c-rifampin in mycobacterium tuberculosis infected mice using dynamic positron emission tomography - V.P. DeMarcoView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Computational pharmacology of rifampin in mice: an application to dose optimization with conflicting objectives in tuberculosis treatment - M. LyonsView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Anti-Tuberculosis Activity of Pyrazinamide Varies by Lesion Type in C3heb/Fej Mice - Lanoix, J.-PView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Intra cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis - R. KempkerView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Inhaled Therapy for TB - Edward Nardell, MDView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Pharmacological Knowledge Gaps in the Treatment of TB Meningitis - Guy Thwaites, MA, MBBS, PhD, FRCP, FRCPath, FMedSciView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014Pharmacokinetics of levofloxacin in M(X)DR tuberculosis patients - N. Van’t Boveneind- VrubleuskayaView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014A semi mechanistic pharmacokinetic-pharmacodynamic template model for studying antitubercular drug effects in vitro - O. CleweView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014A quantitative and systems pharmacology approach to dose optimization in experimental tuberculosis: opportunities and experimental data needs - M. LyonsView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014The inhibitory potential of TB drugs on ATP-binding cassette transporters MRP1- 5, P-gp, BCRP and BSEP - L. Te BrakeView Slideset
